3 Stocks I'm Not Selling, No Matter What the Market Does for the Next 20 Years

The article argues for long-term ownership of Enbridge, Procter & Gamble, and IBM based on durable business models and resilient dividends, citing Enbridge's 5.4% yield and 31 straight years of dividend increases, P&G's nearly 3% yield and Dividend King status, and IBM's 2.6% yield with continued adaptation into cloud, AI, and quantum computing. It highlights Enbridge's shift toward natural gas utilities and clean energy assets, P&G's innovation-led consumer staples leadership, and IBM's $34 billion Red Hat acquisition as evidence of business evolution. Overall, this is a bullish long-term dividend-stock commentary with limited immediate trading impact.

Analysis

The market is rewarding durability over growth optionality here, but the deeper signal is that investors are using dividend narratives as a proxy for balance-sheet resilience and management adaptability. That should keep a bid under ENB, PG, and IBM in a slower-growth tape, while mechanically pressuring lower-quality yielders that lack operating flexibility or pricing power. The second-order effect is a relative-value rotation inside defensives: capital is likely to migrate from “income at any price” into companies that can plausibly re-rate on operating mix shifts, not just payout mechanics.

ENB’s setup is less about yield and more about the market discounting transition risk too aggressively. If regulated utility cash flows keep expanding relative to pure midstream exposure, the equity could de-rate less than peers on any commodity wobble, because the earnings mix becomes easier to underwrite. The flip side is that anything that interrupts capital recycling or raises financing costs will hit ENB harder than the article implies, since the investment case depends on continued asset repositioning rather than static cash generation.

PG is the cleanest quality-income expression, but its real edge is retailer indispensability: shelf power allows it to defend share and margins even if consumer trade-down accelerates. That means the downside is likely slower but more persistent if private label keeps improving; this is a months-to-years margin grind, not a near-term collapse. IBM is the highest beta to execution: the AI and cloud story can support multiple expansion, but only if revenue mix improves faster than investor patience decays, making it the most vulnerable to disappointment over the next 2-4 quarters.

The consensus is underappreciating that these names are not just ‘defensives’—they are capital allocators with embedded strategic transitions. That makes them useful in a regime where investors want yield but still need narrative catalysts. The risk is crowding: if rates back up or bond yields become more attractive, these premium defensives could underperform despite solid fundamentals, because the valuation support is rate-sensitive.

Key Decisions for Investors

• Long PG vs. XLP basket on a 3-6 month horizon: PG’s brand and shelf power should outlast category weak spots, while weaker staples get hit first if private label share keeps rising.
• Add ENB on pullbacks only, size as a 12-24 month income-plus-transition hold: the bull case is mix improvement and utility-like stability; risk is financing spreads and any slowdown in asset rotation.
• Trade IBM as a tactical long only against a lagging software/capex-sensitive peer basket over 1-2 quarters: use upside convexity into AI narrative refresh, but cut quickly if bookings or commentary fail to show acceleration.
• Short high-yield, low-quality dividend names versus PG/ENB/IBM if rates stay sticky: the market is likely to punish unsupported yield more than it rewards the headline yield on stable compounders.
• If 10Y yields rise another 50-75 bps, hedge or trim PG and IBM first; they are the most valuation-sensitive to a higher discount rate, even if fundamentals remain intact.